EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 5 October 2017

#WeWontRest video

Rachelle Doody, Global head of Neurodegeneration, Roche

"#WeWontRest until people with Alzheimer's have treatment options that will give them control and dignity instead of a future of disability"

In this video, Rachelle Doody, Global head of Neurodegeneration at Roche, talks about her lifelong mission to find more and better treatment for Alzheimer's disease.
Read more

Statements

05102017 EFPIA response to BMJ article on efficacy of cancer medicines
05 October 2017

EFPIA calls for stakeholders to work together to optimise our ability to assess value with the tools already at our... Read more

Blogs

05102017 Incentives, IP and Smaller companies: the Story of CureVac
05 October 2017

With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression,... Read more

Events

11 September 2017 2017 ICHOM Conference
25 October 2017 (Washington, D.C.)

Join value-innovators from across the health care spectrum in Washington, D.C. Read more

19 July 2017 War on Cancer – a patient’s journey
21 November 2017 (The HAC, London, UK)

3rd annual conference organised by The Economist Events Read more

14 July 2017 1st European Alliance for Personalised Medicine Congress
27 November 2017 (Belfast, Northern Ireland)

Personalising Your Health: A Global Imperative! Read more

04102017 SafeSciMET Courses on regulatory requirements and guidelines
22 January 2018 (Lisbon, Portugal)

A course to provide participants with a comprehensive overview of the required in vitro and in vivo nonclinical studies,... Read more

What we are reading

Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation
On 04 October 2017 (EurActiv)

Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business... Read more

ADAPTSMART Newsletter
On 04 October 2017 (ADAPTSMART)

You can access the latest issue of the ADAPTSMART newsletter here. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu